TAOXHIGH SIGNALFINANCIAL10-K

TAOX experienced a dramatic deterioration in cash position alongside substantially reduced R&D spending and worsening operating losses.

The company's cash position declined from $17.7M to $5.5M while operating losses expanded to $9.0M, creating potential liquidity concerns given the current burn rate. The sharp reduction in R&D expenses suggests possible budget constraints that could impact the company's development pipeline and future growth prospects.

Comparing 2026-03-31 vs 2025-03-27View on EDGAR →
FINANCIAL ANALYSIS

TAOX's financial position deteriorated meaningfully with cash reserves declining by nearly 70% to $5.5M while operating losses expanded to $9.0M from $6.8M. The company substantially reduced R&D spending, which fell to just $322K, likely reflecting cash conservation efforts. Despite the cash decline, total assets grew to $25.8M, suggesting potential asset revaluations or acquisitions, while total liabilities decreased significantly, indicating possible debt reduction or restructuring activities.

FINANCIAL STATEMENT CHANGES
R&D Expense
P&L
-79.8%
$1.6M→$322K

R&D spending cut 79.8% — could signal cost discipline or concerning reduction in innovation investment.

Current Liabilities
Balance Sheet
+78.8%
$1.0M→$1.8M

Current liabilities surged 78.8% — significant near-term obligations; verify ability to meet short-term debt.

Cash & Equivalents
Balance Sheet
-68.9%
$17.7M→$5.5M

Cash declined 68.9% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Total Liabilities
Balance Sheet
-64.1%
$11.0M→$3.9M

Liabilities reduced 64.1% — deleveraging improves balance sheet strength and financial flexibility.

Capital Expenditure
Cash Flow
-63.5%
$7K→$3K

Capex reduced 63.5% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Total Assets
Balance Sheet
+45.7%
$17.7M→$25.8M

Asset base grew 45.7% — expansion through organic growth, acquisitions, or capital deployment.

Current Assets
Balance Sheet
+43.2%
$17.7M→$25.4M

Current assets grew 43.2% — improving short-term liquidity or inventory/receivables build.

Operating Income
P&L
-32.8%
-$6.8M→-$9.0M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Operating Cash Flow
Cash Flow
-30.9%
-$4.9M→-$6.4M

Operating cash flow fell 30.9% — earnings quality concerns; investigate working capital changes and non-cash items.

LANGUAGE CHANGES
NEW — 2026-03-31
PRIOR — 2025-03-27
ADDED
(Exact name of registrant as specified in its charter) Delaware 46-1585656 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S.
As of March 30, 2026, the registrant had 7,471,931 shares of common stock outstanding.
Market For Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Management s Discussion and Analysis of Financial Condition and Results of Operations.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters.
Certain Relationships and Related Transactions, and Director Independence.
Forward-looking statements generally can be identified by words such as anticipates, believes, estimates, expects, intends, plans, predicts, projects, will be, will continue, will likely result, and similar expressions.
Factors that could cause or contribute to such differences include, but are not limited to those discussed in this report, and in particular, the risks discussed under the caption Risk Factors in Item 1A of this report and those discussed in other documents we file with the SEC.
Forward-looking statements herein speak only as of the date of this report.
REMOVED
Synaptogenix, Inc._DECEMBER 31, 2024 0001571934 --12-31 2024 FY Synaptogenix, Inc.
( Exact name of registrant as specified in its charter) Delaware 46-1585656 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S.
As of March 27, 2025, the registrant had 1,389,815 shares of common stock outstanding.
Market For Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 60 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 60 Item 8.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 69 Item 9A.
Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters 84 Item 13.
Any and all statements contained in this report that are not statements of historical fact may be deemed forward-looking statements.
Terms such as may, might, would, should, could, project, estimate, pro-forma, predict, potential, strategy, anticipate, attempt, develop, plan, help, believe, continue, intend, expect, future, and terms of similar import (including the negative of any of the foregoing) may be intended to identify forward-looking statements.
However, not all forward-looking statements may contain one or more of these identifying terms.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →